top of page

Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults: PrevailGo 3

Overview

On the Phone

Kendzor, D. E. (Principal Investigator), Businelle, M. S. (Co-Investigator), Vidrine, D. J. (Co-Investigator), Pearce-Frank, S. (Co-Investigator), Alexander, A. C. (Co-Investigator), Dallery, J. (Co-Investigator), Shih, Y.-C. (Co-Investigator)

​

​

​

​

PrevailGo 3 is a 5-year, $3.1 million grant from the National Cancer Institute to evaluate the effectiveness of an automated, smartphone-based approach to incentivizing smoking cessation among low-income adults. Individuals initiating smoking cessation treatment will be randomly assigned to either standard smoking cessation treatment or standard treatment plus financial incentives for quitting. Smartphones are provided to participants in order to assess their experiences while quitting and to provide intervention support.

 

To find more information about the study, call (405) 271-QUIT or visit 271quit.com

​

Sponsored by the National Cancer Institute, Federal 

Grant/Contract Number: R01CA251451

2021-2026

bottom of page